(Q73902432)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856790%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856790%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

1 reference

1 reference

1 reference

I Davidkin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856790%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

H Peltola

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856790%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Leinikki

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856790%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Valle

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856790%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856790%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

number of pages

7

1 reference

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856790%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856790%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856790%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

3106-3112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856790%20AND%20SRC:MED&resulttype=core&format=json

Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

No measles in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Rubella antibody persistence after immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Persistence of rubella antibodies 15 years after subcutaneous administration of Wistar 27/3 strain live attenuated rubella virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Duration of immunity after rubella vaccination: a long-term study in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Rubella vaccination: persistence of antibodies for 10-21 years

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Hemolysis-in-gel test in immunity surveys and diagnosis of rubella

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Rubella vaccines: past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Mass vaccination programme aimed at eradicating measles, mumps, and rubella in Sweden: first experience

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Twenty years' experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Rubella Immunity and Morbidity: Effects of Vaccination in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Viremia, Virus Excretion, and Antibody Responses after Challenge in Volunteers with Low Levels of Antibody to Rubella Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Serological response to rubella revaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Persistence of humoral and cell-mediated immunity to rubella virus in cloistered nuns and in schoolteachers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Serological evidence of reinfection among vaccinees during rubella outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Possibility of reinfection after immunisation with RA27/3 live attenuated rubella virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Rubella immunity. Defining the level of protective antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

Rubella immunity and morbidity: impact of different vaccination programs in Finland 1979-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900139-0

7 January 2021

10.1016/S0264-410X(00)00139-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856790%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference